메뉴 건너뛰기




Volumn 43, Issue 4, 2002, Pages 889-891

Graft versus Burkitt's lymphoma effect after allogeneic marrow transplantation

Author keywords

Burkitt's lymphoma; GVHD; Rituximab

Indexed keywords

ALPHA INTERFERON; CD20 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; IFOSFAMIDE; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; METHOTREXATE; MONOCLONAL ANTIBODY; RITUXIMAB; VINCRISTINE;

EID: 0036232494     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190290017051     Document Type: Article
Times cited : (21)

References (15)
  • 1
    • 0028064764 scopus 로고
    • "Revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group"
    • (1994) Blood , vol.84 , pp. 1361-1392
    • Harris, N.L.1    Jaffe, E.S.2    Stein, H.3
  • 2
    • 0003294155 scopus 로고    scopus 로고
    • "International evaluation of National Cancer Institute protocol 89-C-41 (with minor modifications) in adults with non-HIV related Burkitt's lymphoma-a United Kingdom Lymphoma Group (UKLG) study"
    • (abstr. 39)
    • (1999) Proc. ASCO , vol.18
    • Mead, G.1    Sydes, M.2
  • 13
    • 0032736341 scopus 로고    scopus 로고
    • "Tumour lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: High-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia"
    • (1999) Am. J. Hematol , vol.62 , pp. 247-250
    • Yang, H.1    Rosove, M.H.2    Figlin, R.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.